SCHEMBL6996429

SCHEMBL6996429

CC1Oc2ccc([N+](=O)[O-])cc2NC1=S

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
AKR1B1 P15121 1/20 0.39
MAPT P10636 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
NR3C1 P04150 1/20 0.38
PGR P06401 1/20 0.38
AR P10275 1/20 0.38
PSMB8 P28062 1/20 0.38
CHRM1 P11229 1/20 0.38
P2RY6 Q15077 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 1/20 0.38
CAPN9 O14815 1/20 0.37
CASP3 P42574 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7003210 0.89 KMT2A (0.48) ALDH1A1CYP1A2CYP3A4ALOX15HSD17B10
SCHEMBL8112059 0.87 KMT2A (0.47) ALDH1A1CYP1A2CYP3A4ALOX15HSD17B10
SCHEMBL2101407 0.84 PARP1 (0.54) ALDH1A1CYP1A2CYP3A4ALOX15HSD17B10
SCHEMBL2100537 0.84 PARP1 (0.54) ALDH1A1CYP1A2CYP3A4ALOX15HSD17B10
SCHEMBL3590372 0.84 PARP1 (0.54) ALDH1A1CYP1A2CYP3A4ALOX15HSD17B10
SCHEMBL6999391 0.82 KMT2A (0.46) ALDH1A1CYP1A2CYP3A4ALOX15HSD17B10
SCHEMBL7988135 0.75 BRD4 (0.53) ALDH1A1ALOX15HSD17B10MAPTMEN1
SCHEMBL7001440 0.75 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP3A4ALOX15HSD17B10
SCHEMBL6999139 0.75 AKR1B1 (0.39) ALDH1A1CYP1A2CYP3A4AKR1B1MAPT
SCHEMBL7710786 0.74 NR1D1 (0.39) ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
EP-1015437-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-07-05 EP disclosed
WO-1999012915-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-18 WO disclosed